The ethereum.org Translatathon is back
The ethereum.org Translatathon is back this August! This is your chance to contribute to the Ethereum ecosystem by translating Ethereum.org from English into your native language. Not only will you be helping to make Ethereum more accessible, but you’l…
GPT-4o Mini But Mighty | The Brainstorm EP 53
With GPT-4o Mini, can Open AI dominate on all AI fronts? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by ARK Research Associate Jozef Soja to discuss the release of C…
Tesla’s Q2 Disappoints, But There’s More to the Story
Here’s why the second quarter could be better than it appears, and why 2025 can’t come soon enough.
Disney World Wants to Catch Lightning Lane Multi Pass in a Bottle
Disney World introduces enhancements to its premium add-on offering that saves guests time standing in line.
Otis Worldwide (OTIS) Q2 2024 Earnings Call Transcript
OTIS earnings call for the period ending June 30, 2024.
3 Stocks That Could Be Easy Wealth Builders
Beloved brands, simple business models, and decades of proven success make these three stocks easy buy-and-hold choices.
Why Alphabet Stock Is Sinking Today
Alphabet stock is falling despite great Q2 results. Is this a buying opportunity?
AT&T; (T) Q2 2024 Earnings Call Transcript
T earnings call for the period ending June 30, 2024.
Royal Caribbean Stock Has a Lot to Prove This Week
The high-flying cruise line operator just hit an all-time high. It has a telltale financial update coming out on Thursday.
Is Chipotle Stock a Buy After the Post-Stock-Split Drop?
After the record 50-for-1 stock split, CMG stock continued to drop.
2 Top Bargain Stocks Ready for a Bull Run
These proven growth stocks are getting back on track after a couple of difficult years, and they look wildly undervalued.
1 Massive Risk Chipotle Faces Today
Chipotle’s stock is priced to perfection.
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer
With danuglipron, Pfizer could become a major player in the massive GLP-1 agonist market.
Tesla and Alphabet Challenge Nvidia’s Artificial Intelligence (AI) Dominance During Recent Earnings Call
Should Nvidia stock investors be worried?